TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:29 PM EDT

TAO Synergies (TAOX) Interest & Investment Income (2019 - 2026)

TAO Synergies' (TAOX) quarterly Interest & Investment Income came in at $25255.0 in Q2 2026, down 83.47% on a YoY basis from $152798.0 in Q2 2025, and down 28.82% quarter-over-quarter from $35479.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Interest & Investment Income (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Interest & Investment Income for 8 consecutive years, with $25255.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Interest & Investment Income fell 83.47% year-over-year to $25255.0; the trailing twelve-month figure through Jun 2026 stood at $168515.0 (down 79.38% YoY), and the FY2025 full-year result was $442913.0, down 65.29% from the prior year.
  • Interest & Investment Income eased to $25255.0 in Q2 2026 per TAOX's latest filing, from $35479.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $549995.0 in Q3 2023 and bottomed at $4610.0 in Q1 2022.
  • Historically, Interest & Investment Income has averaged $209084.5 across 5 years, with a median of $167049.5 in 2024.
  • The sharpest annual moves came in 2023 and 2025: Interest & Investment Income surged 8497.77% in 2023, then plunged 85.6% in 2025.
  • Over 5 years, Interest & Investment Income stood at $145212.0 in 2022, then jumped by 89.68% to $275439.0 in 2023, then slumped by 34.18% to $181301.0 in 2024, then tumbled by 64.43% to $64489.0 in 2025, then slumped by 60.84% to $25255.0 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $25255.0, $35479.0, and $64489.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn -
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn 120.60 Mn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn -48.00 Mn
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn 48.00 Mn
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn 67.00 Mn
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn 28.14 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn -
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn 36.92 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn - 25,255.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25,255.00
Mar 31, 2026 35,479.00
Dec 31, 2025 64,489.00
Sep 30, 2025 43,292.00
Jun 30, 2025 152,798.00
Mar 31, 2025 182,334.00
Dec 31, 2024 181,301.00
Sep 30, 2024 300,681.00
Jun 30, 2024 330,508.00
Mar 31, 2024 463,395.00
Dec 31, 2023 275,439.00
Sep 30, 2023 549,995.00
Jun 30, 2023 427,159.00
Mar 31, 2023 396,357.00
Dec 31, 2022 145,212.00
Sep 30, 2022 140,730.00
Jun 30, 2022 44,487.00
Mar 31, 2022 4,610.00
Dec 31, 2021 2,518.00
Sep 30, 2021 2,445.00